Irwin Naturals Inc. (IWINF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Irwin Naturals Inc. (IWINF) stock?
Irwin Naturals Inc. (IWINF) no longer trades on public markets. The figures below are historical and are not a current quote.
Market cap $1.68M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Irwin Naturals Inc. (IWINF). Irwin Naturals Inc. distributes CBD products internationally, operating through online channels and approximately 100,000 stores. The company focuses on herbal supplements and wellness products. Market cap: $1.68M, Sector: Healthcare.
Last analyzed: Mar 18, 2026Analyst Coverage for IWINF: IWINF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IWINF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Irwin Naturals Inc. (IWINF) Healthcare & Pipeline Overview
Irwin Naturals Inc. is a herbal supplement company focused on the distribution of CBD products across the United States and internationally. Operating through a network of approximately 100,000 stores and online channels, the company targets the growing market for natural health and wellness solutions, facing competition in the evolving CBD landscape.
What Is the Investment Thesis for IWINF?
Irwin Naturals Inc. presents a focused investment opportunity within the expanding CBD and herbal supplement market. With a wide distribution network of approximately 100,000 stores and an online presence, the company has established market access. Key value drivers include the growth of the CBD market, expansion of product lines, and strategic partnerships to enhance distribution. A potential catalyst is the evolving regulatory landscape for CBD products, which could provide both opportunities and challenges. The company's negative P/E ratio of -0.18 and negative profit margin of -4.5% indicate financial challenges that require careful consideration. Investors should monitor the company's ability to improve profitability and manage regulatory risks.
Based on FMP financials and quantitative analysis
IWINF Key Highlights
Operates in the herbal supplement and CBD product market.
- Distributes products through approximately 100,000 stores and online channels.
- Gross Margin of 45.5% indicates potential for profitability with effective cost management.
- Negative P/E ratio of -0.18 reflects current earnings challenges.
- Beta of -0.10 suggests low volatility compared to the market.
Who Are IWINF's Competitors?
IWINF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MSLE Satellos Bioscience Inc. Common Stock | $10.05 | +0.30% | $13.0M | 345-pillar |
| AIXC AIxCrypto Holdings, Inc. | $0.74 | +4.87% | $15.0M | — |
| NEUP Neuphoria Therapeutics Inc. | $3.73 | -0.53% | $20.2M | 315-pillar |
| RNTX Rein Therapeutics, Inc. | $0.78 | +0.20% | $21.9M | — |
| YI 111, Inc. | $3.45 | +10.22% | $30.1M | 395-pillar |
| KYNB Kyntra Bio, Inc. | $7.97 | -0.81% | $32.3M | — |
| PETS PetMed Express, Inc. | $1.70 | -0.58% | $36.3M | 335-pillar |
| LFMD LifeMD, Inc. | $3.06 | +0.83% | $148M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IWINF's Key Strengths?
Wide distribution network of approximately 100,000 stores.
- Established brand recognition in the herbal supplement market.
- Online sales channel for direct-to-consumer reach.
- Focus on the growing CBD market.
What Are IWINF's Weaknesses?
Negative P/E ratio and profit margin indicate financial challenges.
- Dependence on third-party retailers for distribution.
- Limited information available on R&D and product innovation.
- Exposure to evolving and uncertain regulatory landscape.
What Could Drive IWINF Stock Higher?
Potential changes in CBD regulations could create new market opportunities.
- Expansion of product lines to meet evolving consumer demand.
- Strategic partnerships to enhance distribution and market reach.
What Are the Key Risks for IWINF?
Financial-distress signal — its Altman Z-Score of -0.16 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-21.2%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from other CBD and supplement companies.
- Fluctuations in consumer demand and preferences.
- Regulatory uncertainty and potential restrictions on CBD products.
- Supply chain disruptions and cost increases.
- Negative P/E ratio and profit margin indicate financial challenges.
What Are the Growth Opportunities for IWINF?
- Expansion of Product Lines: Irwin Naturals can capitalize on the growing demand for diverse CBD and herbal supplement products by expanding its product lines to include new formulations, delivery methods, and targeted health solutions. The global herbal medicine market is projected to reach $129.3 billion by 2028, presenting a significant opportunity for Irwin Naturals to increase its market share through innovative product development. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with established retailers, distributors, and healthcare providers can significantly expand Irwin Naturals' market reach and brand recognition. Collaborations with major retail chains or online marketplaces can provide access to a broader customer base and enhance distribution efficiency. The timeline for establishing such partnerships is estimated at 6-12 months.
- International Expansion: Expanding into new international markets presents a significant growth opportunity for Irwin Naturals, particularly in regions with increasing acceptance of CBD and herbal supplements. Identifying and targeting specific countries with favorable regulatory environments and consumer demand can drive revenue growth and diversify the company's market presence. Timeline: 12-24 months.
- Online Channel Optimization: Enhancing the company's online presence and e-commerce capabilities can drive direct-to-consumer sales and improve customer engagement. Investing in user-friendly website design, targeted online marketing campaigns, and efficient order fulfillment processes can increase online sales and brand loyalty. The timeline for optimizing online channels is estimated at 3-6 months.
- Regulatory Tailwinds: The evolving regulatory landscape for CBD products presents both opportunities and challenges for Irwin Naturals. As regulations become more standardized and favorable, the company can benefit from increased market legitimacy and consumer confidence. Monitoring and adapting to regulatory changes will be crucial for capitalizing on this growth opportunity. Timeline: Ongoing.
What Are IWINF's Competitive Advantages?
- Extensive Distribution Network: Access to approximately 100,000 stores provides a wide reach.
- Established Brand: Irwin Naturals has built a recognized brand in the supplement market.
- Online Presence: The company's online platform allows for direct-to-consumer sales.
What Does IWINF Do?
Irwin Naturals Inc., formerly known as Datinvest International Ltd., is a Los Angeles-based company operating within the herbal supplement and CBD product market. The company distributes its products through a wide network of approximately 100,000 stores and online platforms, reaching both domestic and international consumers. Irwin Naturals focuses on providing a range of herbal supplements and CBD products, catering to the increasing consumer demand for natural health and wellness solutions. Founded with a vision to provide accessible and effective herbal supplements, Irwin Naturals has evolved to capitalize on the burgeoning CBD market. The company's strategic focus on distribution through established retail channels and online platforms allows it to reach a broad customer base. Irwin Naturals continues to adapt its product offerings to meet changing consumer preferences and regulatory landscapes within the CBD and supplement industries. The company's commitment to quality and accessibility has established it as a notable player in the competitive market.
What Products and Services Does IWINF Offer?
- Distributes CBD products in the United States and internationally.
- Offers herbal supplements.
- Sells products through approximately 100,000 stores.
- Provides products online.
- Focuses on natural health and wellness solutions.
- Adapts product offerings to meet changing consumer preferences.
How Does IWINF Make Money?
- Sells herbal supplements and CBD products through retail partnerships.
- Generates revenue through online sales.
- Focuses on distribution to a broad customer base.
What Industry Does IWINF Operate In?
Irwin Naturals Inc. operates in the rapidly evolving herbal supplement and CBD market. The industry is characterized by increasing consumer interest in natural health solutions and growing acceptance of CBD products. The competitive landscape includes companies like ACNNF (Accannabis), CANB (Can B Corp), CBDNF (CBD of Denver Inc), ETRGF (EuroTech Holdings Co), and GABLF (Global Asset Backed Corp), each vying for market share. The market is subject to changing regulations and consumer preferences, requiring companies to adapt their strategies to remain competitive. The global CBD market is projected to continue its growth trajectory, presenting opportunities for companies like Irwin Naturals to expand their market presence.
Who Are IWINF's Key Customers?
- Consumers seeking natural health and wellness solutions.
- Individuals interested in CBD products.
- Customers purchasing through retail stores.
- Online shoppers looking for herbal supplements.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
- ● This is an unknown, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 43 |
| 2026-08-24 | 43 |
| 2026-08-25 | 43 |
| 2026-08-26 | 43 |
What changed?
The score has stayed at 43.
Over the same 3 days the stock moved +0.0%.
How Irwin Naturals Inc. Is Valued
Irwin Naturals Inc. carries a market capitalization of $1.68M, placing it in the micro-cap category.
Company Profile
Irwin Naturals Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Los Angeles, US. The company is led by CEO Klee Irwin. IWINF has traded publicly since 2021.
Key Financial Metrics
Return on equity for Irwin Naturals Inc. stands at -21.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -5.1%, showing how much profit it generates from its asset base. A current ratio of 1.24 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
Irwin Naturals Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.16 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
Irwin Naturals Inc. has missed Wall Street's EPS estimate in 3 of its last 3 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 7705.8% below estimates on average.
IWINF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Wide distribution network of approximately 100,000 stores.
- Established brand recognition in the herbal supplement market.
- Online sales channel for direct-to-consumer reach.
- Focus on the growing CBD market.
Bear Case
- Negative P/E ratio and profit margin indicate financial challenges.
- Dependence on third-party retailers for distribution.
- Limited information available on R&D and product innovation.
- Exposure to evolving and uncertain regulatory landscape.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IWINF Latest News
-
Cannabis Stock Gainers And Losers From August 25, 2023
benzinga · Aug 25, 2023
-
Marijuana Stock Movers For August 15, 2023
benzinga · Aug 15, 2023
-
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
benzinga · May 31, 2023
-
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
benzinga · Mar 27, 2023
Latest News
Cannabis Stock Gainers And Losers From August 25, 2023
Marijuana Stock Movers For August 15, 2023
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Leadership: Klee Irwin
CEO
Klee Irwin is the Chief Executive Officer of Irwin Naturals Inc. He has been involved with the company for several years, guiding its strategic direction and growth initiatives. Irwin's background includes experience in business development, marketing, and product innovation within the health and wellness sector. He is focused on expanding the company's market presence and enhancing its product offerings to meet evolving consumer needs.
Track Record: Under Klee Irwin's leadership, Irwin Naturals Inc. has expanded its distribution network and increased its focus on the CBD market. He has overseen the development of new product lines and the implementation of strategic marketing campaigns to drive sales growth. Irwin has also navigated the company through regulatory challenges and evolving market dynamics.
IWINF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that the company may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk. This tier is often associated with speculative investments and requires careful due diligence.
- OTC Tier: OTC Other
- Limited Disclosure: Lack of financial transparency due to the company's disclosure status.
- Low Liquidity: Potential difficulty in buying or selling shares due to low trading volume.
- Price Volatility: Higher price volatility compared to stocks listed on major exchanges.
- Regulatory Uncertainty: Exposure to regulatory risks associated with the OTC market and the CBD industry.
- Speculative Investment: Higher risk due to the speculative nature of OTC Other stocks.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive positioning.
- Review the company's legal and regulatory compliance.
- Analyze the company's capital structure and debt levels.
- Monitor news and press releases for any material developments.
- Consult with a financial advisor to assess the risks and potential rewards.
- Established Distribution Network: The company's access to approximately 100,000 stores suggests a degree of operational scale.
- Online Presence: The company's online platform allows for direct-to-consumer sales.
- Focus on Growing Market: The company's focus on the CBD market aligns with a growing industry trend.
Irwin Naturals Inc. Healthcare Stock: Key Questions Answered
What happened to Irwin Naturals Inc. (IWINF) stock?
Irwin Naturals Inc. (IWINF) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy IWINF shares?
No. IWINF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for IWINF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before IWINF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Irwin Naturals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Irwin Naturals Inc. do?
Irwin Naturals Inc. is a herbal supplement company that distributes CBD products in the United States and internationally. It offers a range of herbal supplements and CBD products through approximately 100,000 stores and online channels.
What are the main risks for IWINF?
The main risks for Irwin Naturals Inc. include intense competition from other CBD and supplement companies, regulatory uncertainty surrounding CBD products, fluctuations in consumer demand, and potential supply chain disruptions.
How does Irwin Naturals Inc. navigate regulatory approval processes?
As a distributor of herbal supplements and CBD products, Irwin Naturals Inc. must navigate a complex regulatory landscape. The company ensures compliance with FDA regulations regarding the manufacturing, labeling, and marketing of its products. While CBD products face evolving regulations, Irwin Naturals monitors and adapts to these changes to maintain compliance.
What is Irwin Naturals Inc.'s competitive strategy in the CBD market?
Irwin Naturals Inc.'s competitive strategy in the CBD market focuses on leveraging its extensive distribution network, established brand recognition, and online presence.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.